(Q42234547)

19 October 2017

Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods (English)

1 reference

19 October 2017

poliovirus

1 reference

3

René H Wijffels

1 reference

19 October 2017

Yvonne E Thomassen

1

1 reference

19 October 2017

Olaf Rubingh

series ordinal

2

1 reference

19 October 2017

Leo A van der Pol

series ordinal

4

1 reference

19 October 2017

Wilfried A M Bakker

series ordinal

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

26 February 2014

1 reference

19 October 2017

1 reference

19 October 2017

32

1 reference

19 October 2017

24

1 reference

19 October 2017

2782-2788

1 reference

Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

High-density microcarrier cell cultures for influenza virus production.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Kinetic characterization of vero cell metabolism in a serum-free batch culture process.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Cost analysis of post-polio certification immunization policies.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Development and optimization of an adenovirus production process

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Growth inhibition in animal cell culture. The effect of lactate and ammonia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Tumorigenicity of Vero cells.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Scale-down of the inactivated polio vaccine production process

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Inhibition of Autographa californica nuclear polyhedrosis virus replication in high-density Trichoplusia ni cell cultures

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5355417

Development of a fast ELISA for quantifying polio D-antigen in in-process samples

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.022

Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.022

Inactivated poliovirus vaccine: current production methods and new developments

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.022

Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24583004

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2014.02.022

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

24583004

1 reference